Insights

European Cannabis Consumption and Regulation

LOS ANGELES-- An extensive report released by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) sheds light on the current state of cannabis consumption and regulation across the European Union. According to the report, approximately 22.2 million adults in the EU, accounting for 7.7% of the population, consumed cannabis in the past year. ...

July 23rd, 2023|

Kernel’s Flow Technology Shows Promise in Analyzing Brain Changes After Ketamine Administration

LOS ANGELES-- A recently published study has revealed promising results for Kernel's Flow technology system, demonstrating its capacity to capture and analyze brain changes following the administration of ketamine, a psychoactive substance. The research, published in the esteemed Nature Journal Scientific Reports and sponsored by psychedelics firm Cybin Inc. (CYBN), specifically focused on measuring the ...

July 23rd, 2023|

New York State Senator Proposes Ban on Public Cannabis Consumption

NEW YORK-- New York State Senator George Borello (R) recently introduced a measure aimed at banning cannabis smoking and consumption in public, unless special authorization has been granted for specific locations. The legislation's Assembly version is sponsored by Republican Assemblyman Michael Novakhov, who seeks to implement rules for cannabis use similar to those in place ...

July 21st, 2023|

Columbia Care’s Cannabist Retail Location in NJ Ratifies First Labor Contract

LOS ANGELES-- The United Food and Commercial Workers (UFCW) union, Local 360, recently announced that the Cannabist retail location in Deptford, NJ, operated by Columbia Care, Inc., has successfully ratified its first labor contract. The contract covers dispensary associates and senior dispensary associates, and its noteworthy feature is the unanimous vote in favor of the ...

July 21st, 2023|

FDA’s Psychedelic Guidance Sparks Interest in Funding and Research Advancement

LOS ANGELES-- In a groundbreaking move, the U.S. Food and Drug Administration (FDA) recently released draft guidance aimed at facilitating research into classic psychedelics, such as LSD, MDMA, and psilocybin, for potential therapeutic uses in mental illness treatment. This marks a significant shift in the medical community's stance towards psychedelic medicine, a field previously regarded ...

July 21st, 2023|

New York City Business Owner Ordered to Forfeit $400,000 in Illegal Cannabis Sales and Unpaid Taxes

NEW YORK-- A business owner in New York City has been ordered to forfeit over $400,000 in illegal proceeds and unpaid taxes after illegally selling cannabis at multiple shops in Manhattan, according to the Associated Press. Rami Alzandani, the owner of the business, reached a non-prosecution agreement with the Manhattan District Attorney's Office, allowing him ...

July 20th, 2023|

61% U.S. Voters Support Legalizing Psychedelic Therapies

SAN FRANCISCO --In a groundbreaking effort, the Berkeley Center for Psychedelic Studies (BCPS) has released the highly anticipated results of their first-ever study on the therapeutic effects of psychedelics. The study, conducted over a span of two years, has ignited hope among researchers and mental health professionals as it sheds light on the potential of ...

July 20th, 2023|

New Study Challenges Link Between Cannabis Use and Psychosis

LOS ANGELES-- Opponents of cannabis and some mainstream media outlets have long claimed that cannabis is detrimental to human brain health, often suggesting a causal link between cannabis use and psychosis. However, a recent study conducted by researchers in the United Kingdom challenges this narrative. The study's findings, published in the journal Psychiatry and Clinical ...

July 19th, 2023|

Cannabis Companies Confront Operational Challenges Amidst Severe Weather

LOS ANGELES-- As severe weather conditions persist, cannabis companies spanning from Northern California to South Florida are grappling with new operational obstacles. The strain on power grids and the aftermath of historic flooding in parts of the Northeast add to the difficulties faced by millions of individuals and businesses across the country due to climate ...

July 19th, 2023|

Compass Pathways’ Psilocybin Treatment Shows Promise for Depression

LONDON-- London-based mental health care company, Compass Pathways (Nasdaq: CMPS), announced encouraging outcomes from a phase 2 clinical trial investigating the efficacy of its synthetic psilocybin treatment, COMP360, in combination with daily SSRI antidepressants for persistent depression. The study involved 19 individuals with treatment-resistant depression and examined the safety and effectiveness of a single 25mg ...

July 18th, 2023|

Canadian Cannabis Entrepreneurs Turn to Micro-Cultivation to Tackle Oversupply

TORONTO-- In response to a surplus of cannabis and declining prices within the Canadian cannabis industry, cannabis entrepreneurs are increasingly embracing smaller micro-cultivation facilities as a means to reduce costs and produce higher-quality cannabis. This shift toward micro-class licenses, which operate smaller cultivation spaces, has the potential to alleviate the current supply glut in the ...

July 17th, 2023|

Ohio Adds Irritable Bowel Syndrome to Medical Cannabis Qualifying Conditions

LOS ANGELES-- On July 12, the State Medical Board of Ohio announced its decision to include irritable bowel syndrome (IBS) in the state's list of qualifying conditions for medical cannabis. However, the board rejected the addition of autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD) to the list. The Ohio Medical Cannabis Industry Association (OMCIA), ...

July 17th, 2023|

Red Lake Nation to Open Minnesota’s First Native American Adult-Use Cannabis Store

LOS ANGELES --In a significant development for Minnesota's cannabis industry, the Red Lake Nation has voted to allow NativeCare Dispensary, an existing tribal medical cannabis dispensary, to commence sales to individuals aged 21 and older starting August 1. This decision positions the Native American tribal dispensary as a potential frontrunner in Minnesota's recreational marijuana market. ...

July 17th, 2023|

States Collaborate with Federal Regulators in Sharing Cannabis Data for Rescheduling Review

LOS ANGELES-- In a significant development, several states with medical cannabis programs have collaborated with U.S. health regulators to provide crucial data regarding cannabis use and its impact on patients. This information, including details about the specific cannabis products utilized and their effects, has been shared as part of the Biden administration's review to assess ...

July 14th, 2023|

Illinois Social Equity License Winners Face Challenges in Opening Cannabis Shops

ILLINOIS-- The 55 winners of the upcoming Illinois social equity license lottery, set to be announced on Thursday, may encounter difficulties in successfully launching their cannabis businesses. Historical data indicates that only a fraction of previously awarded social equity licenses have managed to open their doors for business. The Illinois Department of Financial and Professional ...

July 13th, 2023|

FDA and FTC Warn Companies Selling Delta-8 THC Foods for Safety Violations

LOS ANGELES-- The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have jointly taken action against six companies for illegally selling food products containing delta-8 THC, a hemp-derived compound. Warning letters were issued to Delta Munchies, Dr. Smoke LLC, Exclusive Hemp Farms/Oshipt, Nikte's Wholesale LLC, North Carolina Hemp Exchange LLC, and ...

July 13th, 2023|

New York Secures $150 Million Investment to Fully Fund Social Equity Cannabis Retailers

LOS ANGELES--  In a significant boost to New York's social equity cannabis program, Chicago Atlantic Admin LLC has committed up to $150 million in senior secured capital for the Social Equity Cannabis Investment Fund. The announcement, made by Gov. Kathy Hochul's office on Friday, ensures that the $200 million fund aimed at supporting social equity ...

July 3rd, 2023|

Australia Becomes the First Country to Allow Prescription of Psychedelics for PTSD and Depression

LOS ANGELES-- Starting from July 1, doctors in Australia can now prescribe MDMA and psilocybin to patients suffering from post-traumatic stress disorder (PTSD) and hard-to-treat depression. This groundbreaking move makes Australia the first nation in the world to permit the prescription of psychedelics as therapeutic medicine. The announcement of these reforms was made in February ...

July 3rd, 2023|

New Jersey’s Cannabis Market Faces Plateau in Sales Amid Regulatory Challenges

LOS ANGELES-- Despite the growth of New Jersey's adult-use cannabis market during the first quarter of 2023, the state's overall sales figures have hit a nine-month plateau due to ongoing regulatory developments and the slow approval of new license applications. Licensed dispensaries reported approximately $145 million in adult-use sales and roughly $34.5 million in medical ...

July 2nd, 2023|

Canadian Government Invests $3 Million in Psilocybin-Assisted Psychotherapy Trials

LOS ANGELES-- The advancement of psychedelic medicine in Canada received a significant boost as the Minister of Mental Health and Addictions, Carolyn Bennett, announced an investment of nearly $3 million through the Canadian Institutes of Health Research. This funding will support three clinical trials exploring the potential of psilocybin-assisted psychotherapy as a treatment option for ...

June 30th, 2023|

Cannabis Industry Struggles Amid Worsening Economic Conditions, Report Finds

LOS ANGELES-- In a new report published by Whitney Economics, it becomes evident that the cannabis industry in the United States is grappling with worsening economic conditions. The report, titled "Cannabis Operator Sentiment and Business Conditions Survey," sheds light on the challenges faced by plant-touching businesses, which are experiencing a decline in sales and profitability. ...

June 30th, 2023|
Go to Top